Directory

>

Paul Ashton

avatar

Paul Ashton

President and CEO | EyePoint Pharmaceuticals

Watertown, Massachusetts, United States

View contact details (it's free)

Paul Ashton

Summary

Paul Ashton is a seasoned biopharmaceutical executive with over 15 years of experience, currently serving as President and CEO of Inflammasome Therapeutics, Ltd. His leadership has been pivotal in developing sustained-release products that are among the few approved by the FDA for back-of-the-eye diseases. With a robust background in biotechnology and drug delivery, Paul has successfully raised significant funding and established strategic collaborations worth over $130 million. He is recognized for his ability to adapt strategies in response to market dynamics, demonstrating resilience during corporate restructuring. An internationally acknowledged scientist with over 200 publications and 120 patents, Paul has cultivated strong relationships with the FDA and Wall Street, enhancing his company's financial stability. His team-building skills are reflected in an impressive average employee tenure of over eight years, showcasing his commitment to fostering a collaborative work environment.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Paul Ashton

Work Experience

💼

President and CEO at

Inflammasome Therapeutics

January 2017 - Present

company logo

President, Chief Executive Officer and a Director at

EyePoint Pharmaceuticals

January 2008 - Present

company logo

Managing Director (CEO) 2008, Director of Strategy 2006-2007, Director at

Psivida

January 2006 - January 2008

company logo

Company Founder, President and CEO 1996-2005; Vice President, Head of R&D 1992-1995 at

Control Delivery Systems, Inc.

January 1992 - January 2005

company logo

Assistant Professor Ophthalmology at

New England Eye Center

January 1995 - January 2000

company logo

Assistant Professor, Joint Appointments in Ophthalmology, Neurosurgery and Pharmacology at

University of Kentucky

January 1988 - January 1994

company logo

Research Scientist (pre-Ph.D) at

ROCHE LEON HOLDINGS

January 1983 - January 1984

Logos provided by Logo.dev

Paul Ashton

Education

University of Southern California

January 1987 - January 1988

University of Wales, Cardiff, Doctor Of Philosophy (Ph.D.)

January 1984 - January 1987

Durham University, Bachelor’s Degree

January 1979 - January 1982

Frequently Asked Questions about Paul Ashton

What is Paul Ashton email address?

Paul Ashton's primary email address is *******@eyepointpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Paul Ashton work for?

Paul Ashton is a President and CEO at EyePoint Pharmaceuticals, a company specializing in Commercial physical research.

Where Paul Ashton graduated from?

Paul Ashton holds a degree in Post Doctoral Fellowship from University of Southern California.

How can I directly contact Paul Ashton?

To contact Paul Ashton directly, you can use the email address *******@eyepointpharma.com. Complete contact information is available upon registration with Muraena.

Who is Paul Ashton?

Paul Ashton is a seasoned biopharmaceutical executive with over 15 years of experience, currently serving as President and CEO of Inflammasome Therapeutics, Ltd. His leadership has been pivotal in developing sustained-release products that are among the few approved by the FDA for back-of-the-eye diseases. With a robust background in biotechnology and drug delivery, Paul has successfully raised significant funding and established strategic collaborations worth over $130 million. He is recognized for his ability to adapt strategies in response to market dynamics, demonstrating resilience during corporate restructuring. An internationally acknowledged scientist with over 200 publications and 120 patents, Paul has cultivated strong relationships with the FDA and Wall Street, enhancing his company's financial stability. His team-building skills are reflected in an impressive average employee tenure of over eight years, showcasing his commitment to fostering a collaborative work environment.

Paul`s contact details

mail

*******@eyepointpharma.com

***********@att.net

Colleagues

avatar
Said Saim

Senior Vice President and Chief Technology Officer

avatar
Ron Honig

Chief Legal Officer & Company Secretary

avatar
Michael Pine

Chief Business Officer

avatar
Michelle Poole

VP, Chief of Staff

avatar
Monica Roy

Vice President, Clinical Development -Ophthalmology

avatar
Ellie Smith

Vice President, Clinical Operations

avatar
David Vario

Vice President Of Quality

avatar
Jon Johnson

VP, Market Access Strategy, Reimbursement and Government Affairs

avatar
Heidi Kraus

Vice President, Intellectual Property

View Contact details (it's free)
Request Profile Removal